Back to Search

CAROLYN BOTROS, DO

DO

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

NPI: 1003243361IndividualAccepts Medicare

Specialties, Licenses & Credentials

Obstetrics & Gynecology Physician

Obstetrics & Gynecology

Code: 207V00000X

25MB09350900(NJ)
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianPrimary

Obstetrics & Gynecology — Urogynecology and Reconstructive Pelvic Surgery

Code: 207VF0040X

036137699(IL)OS019448(PA)

CMS Specialties

PrimaryOBSTETRICS/GYNECOLOGY

Education

ROWAN UNIVERSITY SCHOOL OF OSTEOPATHIC MEDICINE

Class of 2011

Clinical Trials (1)

1
Linked Trials
1
Recruiting
0
With Results

Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA

NCT05519072RECRUITINGPHASE4PRINCIPAL_INVESTIGATOR

Research & Publications (11)

Antibiotic regimen and route of administration do not alter rates of urinary tract infection after intravesical botulinum toxin injection for overactive bladder.
PMID 33594517·Int Urogynecol J·2022
8-other
Antibiotic resistance and persistence-Implications for human health and treatment perspectives.
PMID 33400359·EMBO Rep·2020
6-review
Best Practice Statement on Urologic Procedures and Antimicrobial Prophylaxis.
PMID 31441676·J Urol·2020
6-review
Crossroads of Antibiotic Resistance and Biosynthesis.
PMID 31288031·J Mol Biol·2019
6-review
What is the ideal antibiotic prophylaxis for intravesically administered Botox injection? A comparison of two different regimens.
PMID 30074062·Int Urogynecol J·2019
4-observational
Use of prophylactic antibiotics for intra-vesicle Botox® injection.
PMID 27177011·Neurourol Urodyn·2017
8-other
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study.
PMID 27038769·J Urol·2016
3-trial
Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis--Different Mechanisms of Action of Botox on Bladder Dysfunction?
PMID 26999201·Toxins (Basel)·2016
4-observational
Patient preferences for treating refractory overactive bladder in the UK.
PMID 26347077·Int Urol Nephrol·2015
8-other
OnabotulinumtoxinA 100U provides significant improvements in overactive bladder symptoms in patients with urinary incontinence regardless of the number of anticholinergic therapies used or reason for inadequate management of overactive bladder.
PMID 24754838·Int J Clin Pract·2014
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
1770 BATHGATE RD STE 401
BETHLEHEM, PA 18017

Quick Facts

NPI
1003243361
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
3
Locations
1
Years in Practice
15
Clinical Trials
1
Publications
11

Are you this provider?

Claim Your Profile